139 related articles for article (PubMed ID: 29118740)
21. A Trypsin Inhibitor from
Nova ICV; Moreira LR; Torres DJL; Oliveira KKDS; Patriota LLS; Coelho LCBB; Paiva PMG; Napoleão TH; Lorena VMB; Pontual EV
Antibiotics (Basel); 2020 Aug; 9(8):. PubMed ID: 32823803
[No Abstract] [Full Text] [Related]
22. Cyclooxygenase (COX)-2 Inhibitors Reduce
Pereira ACA; Silva RJ; Franco PS; de Oliveira Gomes A; Souza G; Milian ICB; Ribeiro M; Rosini AM; Guirelli PM; Ramos ELP; Mineo TWP; Mineo JR; Silva NM; Ferro EAV; Barbosa BF
Front Microbiol; 2019; 10():225. PubMed ID: 30809216
[No Abstract] [Full Text] [Related]
23. The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection.
Ouaissi A; Guilvard E; Delneste Y; Caron G; Magistrelli G; Herbault N; Thieblemont N; Jeannin P
J Immunol; 2002 Jun; 168(12):6366-74. PubMed ID: 12055254
[TBL] [Abstract][Full Text] [Related]
24. The role of IL-12 in experimental Trypanosoma cruzi infection.
Silva JS; Aliberti JC; Martins GA; Souza MA; Souto JT; Pádua MA
Braz J Med Biol Res; 1998 Jan; 31(1):111-5. PubMed ID: 9686186
[TBL] [Abstract][Full Text] [Related]
25. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
Zwolinska-Wcislo M; Krzysiek-Maczka G; Ptak-Belowska A; Karczewska E; Pajdo R; Sliwowski Z; Urbanczyk K; Drozdowicz D; Konturek SJ; Pawlik WW; Brzozowski T
J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697
[TBL] [Abstract][Full Text] [Related]
26. Dual role of monocyte-derived dendritic cells in Trypanosoma cruzi infection.
Poncini CV; González-Cappa SM
Eur J Immunol; 2017 Nov; 47(11):1936-1948. PubMed ID: 28748529
[TBL] [Abstract][Full Text] [Related]
27. Neurodegeneration and increased production of nitrotyrosine, nitric oxide synthase, IFN-gamma and S100beta protein in the spinal cord of IL-12p40-deficient mice infected with Trypanosoma cruzi.
Bombeiro AL; D'Império Lima MR; Chadi G; Alvarez JM
Neuroimmunomodulation; 2010; 17(2):67-78. PubMed ID: 19923851
[TBL] [Abstract][Full Text] [Related]
28. Molecular basis of Trypanosoma cruzi-induced immunosuppression. Altered expression by activated human lymphocytes of molecules which regulate antigen recognition and progression through the cell cycle.
Kierszenbaum F; Moretti E; Sztein MB
Biol Res; 1993; 26(1-2):197-207. PubMed ID: 7670532
[TBL] [Abstract][Full Text] [Related]
29. Production of MMP-9 and inflammatory cytokines by Trypanosoma cruzi-infected macrophages.
de Pinho RT; da Silva WS; de Castro Côrtes LM; da Silva Vasconcelos Sousa P; de Araujo Soares RO; Alves CR
Exp Parasitol; 2014 Dec; 147():72-80. PubMed ID: 25448360
[TBL] [Abstract][Full Text] [Related]
30. AgC10, a mucin from Trypanosoma cruzi, destabilizes TNF and cyclooxygenase-2 mRNA by inhibiting mitogen-activated protein kinase p38.
Alcaide P; Fresno M
Eur J Immunol; 2004 Jun; 34(6):1695-704. PubMed ID: 15162440
[TBL] [Abstract][Full Text] [Related]
31. Aspirin treatment exacerbates oral infections by Trypanosoma cruzi.
Cossentini LA; Da Silva RV; Yamada-Ogatta SF; Yamauchi LM; De Almeida Araújo EJ; Pinge-Filho P
Exp Parasitol; 2016 May; 164():64-70. PubMed ID: 26826555
[TBL] [Abstract][Full Text] [Related]
32. Effect of the saliva from different triatomine species on the biology and immunity of TLR-4 ligand and Trypanosoma cruzi-stimulated dendritic cells.
Mendes MT; Carvalho-Costa TM; da Silva MV; Anhê AC; Guimarães RM; da Costa TA; Ramirez LE; Rodrigues V; Oliveira CJ
Parasit Vectors; 2016 Dec; 9(1):634. PubMed ID: 27938380
[TBL] [Abstract][Full Text] [Related]
33. IL-10 participates in the expansion and functional activation of CD8
Pino-Martínez AM; Miranda CG; Batalla EI; González-Cappa SM; Alba Soto CD
J Leukoc Biol; 2019 Jan; 105(1):163-175. PubMed ID: 30371945
[TBL] [Abstract][Full Text] [Related]
34. IL-12 enhances proliferation of peripheral blood mononuclear cells from Chagas' disease patients to Trypanosoma cruzi antigen.
de Barros-Mazon S; Guariento ME; Abrahamsohn IA
Immunol Lett; 1997 Jun; 57(1-3):39-45. PubMed ID: 9232423
[TBL] [Abstract][Full Text] [Related]
35. Central role of extracellular signal-regulated kinase and Toll-like receptor 4 in IL-10 production in regulatory dendritic cells induced by Trypanosoma cruzi.
Poncini CV; Giménez G; Pontillo CA; Alba-Soto CD; de Isola EL; Piazzón I; Cappa SM
Mol Immunol; 2010 Jul; 47(11-12):1981-8. PubMed ID: 20537708
[TBL] [Abstract][Full Text] [Related]
36. Effects of aspirin-triggered resolvin D1 on peripheral blood mononuclear cells from patients with Chagas' heart disease.
Ogata H; Teixeira MM; Sousa RC; Silva MV; Correia D; Rodrigues Junior V; Levy BD; Rogério Ade P
Eur J Pharmacol; 2016 Apr; 777():26-32. PubMed ID: 26927755
[TBL] [Abstract][Full Text] [Related]
37. Suppression by Trypanosoma cruzi of T-cell receptor expression by activated human lymphocytes.
Sztein MB; Kierszenbaum F
Immunology; 1992 Oct; 77(2):277-83. PubMed ID: 1427979
[TBL] [Abstract][Full Text] [Related]
38. Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients.
Pérez-Antón E; Egui A; Thomas MC; Puerta CJ; González JM; Cuéllar A; Segovia M; López MC
PLoS Negl Trop Dis; 2018 May; 12(5):e0006480. PubMed ID: 29750791
[TBL] [Abstract][Full Text] [Related]
39. Dendritic cells devoid of IL-10 induce protective immunity against the protozoan parasite Trypanosoma cruzi.
Alba Soto CD; Solana ME; Poncini CV; Pino-Martinez AM; Tekiel V; González-Cappa SM
Vaccine; 2010 Oct; 28(46):7407-13. PubMed ID: 20850535
[TBL] [Abstract][Full Text] [Related]
40. Activation of Human CD11b
Passos LSA; Magalhães LMD; Soares RP; Marques AF; Alves MLR; Giunchetti RC; Nunes MDCP; Gollob KJ; Dutra WO
Front Immunol; 2018; 9():3015. PubMed ID: 30662439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
